Biohaven BHVN Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -333%-22.2pp | -310.8%— | —— | -295.9%+20.9pp | -316.8%-118pp | |
| Return on assets | -140%-1.4pp | -138.5%+31.1pp | -169.7%-34.3pp | -135.4%+67.2pp | -202.5%-52.5pp | |
| Return on invested capital | -395.4%-72.3pp | -323.1%+110pp | -433.6%-59.4pp | -374.2%+173pp | -547.4%-234pp | |
| Liquidity | ||||||
| Current ratio | 7.4×+4.2× | 3.2×+0.3× | 2.9×-1.0× | 3.8×+1.5× | 2.3×-1.2× | |
| Quick ratio | 7.4×+4.2× | 3.2×+0.3× | 2.9×-1.0× | 3.8×+1.5× | 2.3×-1.2× | |
| Cash ratio | 5.3×+3.3× | 2×+0.3× | 1.7×+0.3× | 1.4×+0.7× | 0.6×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 2.2×-3.3× | 5.5×— | —— | 2.2×+2.0× | 0.1×+0.1× | |
| Debt-to-assets | 0.6×0.0× | 0.6×-0.1× | 0.8×+0.2× | 0.5×+0.5× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $0.88+81.3% | $0.48+398% | -$0.16-112% | $1.31-48.4% | $2.55-45.2% | |
| Valuation | ||||||
| Market capitalization | $1.27B-15.1% | $1.5B-5.7% | $1.59B+5.3% | $1.51B-38.5% | $2.45B-35.0% | |
| Enterprise value | $1.28B-17.3% | $1.55B-9.6% | $1.71B+5.1% | $1.63B-31.7% | $2.39B-35.7% | |
| Price / book | 9.8×-18.9× | 28.8×— | —— | 11.2×+1.8× | 9.5×+0.5× | |
| Free cash flow yield | -46.7%-6.0pp | -40.7%+0.2pp | -41%+1.9pp | -42.9%-16.4pp | -26.5%-10.9pp | |
| Earnings yield | -50.9%-1.6pp | -49.3%-0.2pp | -49.1%+1.7pp | -50.9%-14.6pp | -36.2%-13.8pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Biohaven's ratios come from?
- Every ratio is computed from Biohaven's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.